Chloroquine resistance in the malarial parasite, Plasmodium falciparum

Medicinal Research Reviews

Volumn 22, Issue 5, 2002, Pages 465-491

  Ursos, Lyann M B ^a   Roepe, Paul D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Chloroquine; Drug transport; Hemozoin; Malaria; Pfcrt; Pfmdr; pH

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HEMATIN; HEMOGLOBIN;

DRUG DIFFUSION; DRUG MECHANISM; DRUG TRANSPORT; GENETIC POLYMORPHISM; MALARIA; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE; PARTITION COEFFICIENT; PH; PLASMODIUM FALCIPARUM; REVIEW; THEORY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; PLASMODIUM FALCIPARUM;

EID: 0036720312     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10016     Document Type: Review

References (94)

1. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
2. Are ion-exchange processes central to understanding drug-resistance phenomena?
3. Altered drug translocation mediated by the MDR protein: Direct, indirect, or both?
4. 4-Aminoquinoline resistance of Plasmodium falciparum: Insights from the study of amodiaquine uptake
5. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect
6. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound
7. Pghl modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
8. + exchanger determines chloroquine uptake in Plasmodium falciparum
9. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
10. + antiporter that is physiologically important at elevated pH
11. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand
12. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
13. pH and multidrug resistance
14. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross
15. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum
16. Lower electrical membrane potential and altered pHi homeostasis in multidrug resistant cells: Further characterization of a series of MDR cell lines expressing different levels of p-glycoprotein
17. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
18. Biophysical aspects of p-glycoprotein-mediated multidrug resistance
19. Analysis of the steady state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of p-glycoprotein
20. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: A catabolic pathway initiated by a specific aspartic protease
21. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum
22. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum
23. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum
24. Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production
25. Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei
26. A Plasmodium falciparum aminopeptidase gene belonging to the M1 family of zinc-metallopeptidases is expressed in erythrocytic stages
27. Malaria pigment
28. Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and beta-hematin
29. Studies on the nature of malaria pigment (hemozoin)
30. An iron-carboxylate bond links the heme units of malaria pigment
31. Characterization of the malaria pigment (hemozoin) from the avian malaria parasite Plasmodium lophurae
32. Biochemical characterization of Plasmodium falciparum hemozoin
33. Plasmodium lophurae: Composition and properties of hemozoin, the malarial pigment
34. The composition of haemozoin from Plasmodium falciparum
35. The state of ferriprotoporphyrin IX in malaria pigment
36. Characterization of the products of the heme detoxification pathway in malarial late trophozoites by X-ray diffraction
37. Heme polymerization in malaria
38. The structure of malaria pigment beta-haematin
39. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
40. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein
41. The chemical mechanism of beta-haematin formation studied by Mössbauer spectroscopy
42. The mechanism of beta-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes
43. Spectroscopic characterization of the heme-binding sites in Plasmodium falciparum histidine-rich protein 2
44. Recent studies of the mineral phase in bone and its possible linkage to the organic matrix by protein-bound phosphate bonds
45. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment)
46. Effects of antimalarials and protease inhibitors on plasmodial hemozoin production
47. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: Possible implication in the resistance to malaria conferred by the beta-thalassemia trait
48. Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation
49. Metalloporphyrins inhibit beta-hematin (hemozoin) formation
50. Aggregation of ferrihaems. Dimerization and protolytic equilibria of protoferrihaem and deuteroferrihaem in aqueous solution
51. The soret band of monomeric hematin and its changes on polymerization
52. The effect of aggregation inhibitors and antioxidants on the stability of hemin solutions
53. Dissociation of aggregated ferroheme complexes and protoporphyrin IX by water-soluble polymers
54. Resonance light scattering and its application in determining the size, shape, and aggregation number for supramolecular assemblies of chromophores
55. Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena
56. The structure of haem in pyridine/water mixtures and its implication in studies of haem catabolism
57. The dimerization of ferrihaems. IV. Studies on haematoferrihaem and a general appraisal of the nature and implications of dimerization
58. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum
59. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum
60. 4-Aminoquinolines - Past, present and future: A chemical perspective
61. The basis of antimalarial action: Non-weak base effects of chloroquine on acid vesicle pH
62. Quinoline-containing antimalarials - Mode of action, drug resistance and its reversal. An update with unresolved puzzles
63. On the molecular mechanism of chloroquine's antimalarial action
64. Access to hematin: The basis of chloroquine resistance
65. Morphological effects of chloroquine on Plasmodium berghei in mice
66. Chloroquine resistance in malaria: Accessibility of drug receptors to mefloquine
67. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials
68. What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance?
69. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine
70. 3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum
71. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug
72. Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance
73. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification od the pfmdr1 gene and cross-resistance to halofantrine and quinine
74. Evidence for electrogenic accumulation of mefloquine by malarial parasites
75. In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand
76. The role of drug accumulation in 4-aminoquinoline antimalarial potency. The influence of structural substitution and physicochemical properties
77. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine
78. The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine
79. + exchangers
80. + exchanger of Plasmodium falciparum?
81. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH
82. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH
83. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America
84. Complex polymorphisms in an approximately 330-kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa
85. Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum
86. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
87. Chloroquine-resistant malaria
88. Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum
89. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7
90. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT produce chloroquine resistance and unique stereospecific quinine and quinidine responses in plasmodium falciparum
91. A molecular marker for chloroquine-resistant falciparum malaria
92. Protein kinase C-mediated phosphorylation of the human multidrug resistance p-glycoprotein regulates cell volume-activated chloride channels